(Q44592013)

4 December 2017

Long-term protection of chimpanzees against high-dose HIV-1 challenge induced by immunization (English)

1 reference

4 December 2017

0 references

20

Gallo RC

1 reference

4 December 2017

Marjorie Robert-Guroff

22

object named as

Robert-Guroff M

1 reference

4 December 2017

12

Zolla-Pazner S

1 reference

4 December 2017

Lubeck MD

1

1 reference

4 December 2017

Natuk R

2

1 reference

4 December 2017

Myagkikh M

3

1 reference

4 December 2017

Kalyan N

4

1 reference

4 December 2017

Aldrich K

5

1 reference

4 December 2017

Sinangil F

6

1 reference

4 December 2017

Alipanah S

7

1 reference

4 December 2017

Murthy SC

8

1 reference

4 December 2017

Chanda PK

9

1 reference

4 December 2017

Nigida SM Jr

10

1 reference

4 December 2017

Markham PD

11

1 reference

4 December 2017

Steimer K

13

1 reference

4 December 2017

Wade M

14

1 reference

4 December 2017

Reitz MS Jr

15

1 reference

4 December 2017

Arthur LO

16

1 reference

4 December 2017

Mizutani S

17

1 reference

4 December 2017

Davis A

18

1 reference

4 December 2017

Hung PP

19

1 reference

4 December 2017

Eichberg J

21

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 June 1997

1 reference

4 December 2017

1 reference

4 December 2017

3

1 reference

4 December 2017

651-658

1 reference

4 December 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/nm0697-651

4 December 2017

0 references

cites work

Effect of immunization with a vaccinia-HIV env recombinant on HIV infection of chimpanzees.

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

Immune response of chimpanzees after immunization with the inactivated whole immunodeficiency virus (HIV-1), three different adjuvants and challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

Protection of MN-rgp120-immunized chimpanzees from heterologous infection with a primary isolate of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

High level expression of the envelope glycoproteins of the human immunodeficiency virus type I in presence of rev gene using helper-independent adenovirus type 7 recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

Anti-cell antibody in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

Human immunodeficiency virus type 1 challenge of chimpanzees immunized with recombinant envelope glycoprotein gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Challenge of chimpanzees (Pan troglodytes) immunized with human immunodeficiency virus envelope glycoprotein gp120

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Immunization of chimpanzees confers protection against challenge with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Vaccine protection of chimpanzees against challenge with HIV-1-infected peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Vaccine-induced protection of chimpanzees against infection by a heterologous human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Immunogenicity of recombinant human adenovirus-human immunodeficiency virus vaccines in chimpanzees

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Immunogenicity of recombinant adenovirus-human immunodeficiency virus vaccines in chimpanzees following intranasal administration

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Failure of a human immunodeficiency virus type 1 (HIV-1) subtype B-derived vaccine to prevent infection of chimpanzees by an HIV-1 subtype E strain

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Nonaffinity purification of recombinant gp120 for use in AIDS vaccine development

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Titration of a vaccine stock preparation of human immunodeficiency virus type 1SF2 in cultured lymphocytes and in chimpanzees

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

A resting cell assay for improved detection of antibody-mediated neutralization of HIV type 1 primary isolates

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Resistance of chimpanzees immunized with recombinant gp120SF2 to challenge by HIV-1SF2.

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus.

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Antibody-mediated in vitro neutralization of human immunodeficiency virus type 1 abolishes infectivity for chimpanzees

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method.

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Immunogenicity and efficacy testing in chimpanzees of an oral hepatitis B vaccine based on live recombinant adenovirus

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Helper T-cell antigenic site identification in the acquired immunodeficiency syndrome virus gp120 envelope protein and induction of immunity in mice to the native protein using a 16-residue synthetic peptide

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Induction of HIV-1 envelope (gp120)-specific cytotoxic T lymphocyte responses in mice by recombinant CHO cell-derived gp120 is enhanced by enzymatic removal of N-linked glycans.

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

A single amino acid interchange yields reciprocal CTL specificities for HIV-1 gp160

1 reference

https://api.crossref.org/works/10.1038%2FNM0697-651

7 January 2021

Identifiers

DOI

10.1038/NM0697-651

1 reference

4 December 2017

1 reference